Metraipolis › archive › dc_bf1c08356a30
Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression — Europe PMC PMID:41291120
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41291120
- DOI
- 10.1038/s41598-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T06:38:40.285Z
- SHA-256 of the archived text
7a2bc10275288caac7201a05fe1550ccd34d53d7996443d34dce24b8892af980- Stable URL of this page
https://metraipolis.com/documento/dc_bf1c08356a30
How to cite
Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression — Europe PMC PMID:41291120 — Europe PMC (en), https://europepmc.org/article/MED/41291120 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bf1c08356a30 (Metraipolis archive dc_bf1c08356a30, sha256 7a2bc10275288caac7201a05fe1550ccd34d53d7996443d34dce24b8892af980)
BibTeX
@misc{dcbf1c08356a30,
title = {Intravenous administration of CpG7909 lipoplex enhances anti-PD1 immunotherapy by modulating the tumor microenvironment and inducing durable tumor regression — Europe PMC PMID:41291120},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41291120},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bf1c08356a30; sha256 7a2bc10275288caac7201a05fe1550ccd34d53d7996443d34dce24b8892af980},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41291120. Agents can read the archived copy with the MCP tool read_document.